STANDARD BIOTOOLS INC.
Standard BioTools Inc. , previously known as Fluidigm Corp. , is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic… (via Wikipedia)
Market & Alt Data
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-04 | 2025-12-04 | Casdin Partners Master Fund, L.P. | Director | Purchase | 150.0K | $1.45 | $217K | 72.10M | View | |
| 2025-12-03 | 2025-12-04 | Casdin Partners Master Fund, L.P. | Director | Purchase | 75.0K | $1.44 | $108K | 71.95M | View | |
| 2025-12-02 | 2025-12-04 | Casdin Partners Master Fund, L.P. | Director | Purchase | 125.0K | $1.42 | $178K | 71.88M | View | |
| 2025-11-25 | 2025-11-26 | Casdin Partners Master Fund, L.P. | Director | Purchase | 7.55M | $1.30 | $9.84M | 71.75M | View | |
| 2025-11-24 | 2025-11-26 | Casdin Partners Master Fund, L.P. | Director | Purchase | 150.0K | $1.43 | $215K | 64.20M | View |
Informational purposes only, not investment advice.
tormere.com/research/LAB · generated 2026-11-04
Standard BioTools Inc. , previously known as Fluidigm Corp. , is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic…
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2025-12-04 | Casdin Partners Master Fund, L.P. | P | 150,000 | $217,020 |
| 2025-12-03 | Casdin Partners Master Fund, L.P. | P | 75,000 | $108,037.5 |
| 2025-12-02 | Casdin Partners Master Fund, L.P. | P | 125,000 | $177,512.5 |
| 2025-11-25 | Casdin Partners Master Fund, L.P. | P | 7,550,000 | $10M |
| 2025-11-24 | Casdin Partners Master Fund, L.P. | P | 150,000 | $214,875 |
Tormere — informational purposes only, not investment advice.
| Filed | Items | Filing |
|---|---|---|
Nov 3, 2026 accepted 8:23 AM ET | 7.01Reg FD disclosure | DocumentSEC ↗ |
Oct 5, 2026 accepted 4:16 PM ET | 7.01Reg FD disclosure | DocumentSEC ↗ |
Sep 30, 2026 accepted 5:27 PM ET | 1.01Material agreement1.02Agreement terminated7.01Reg FD disclosure | DocumentSEC ↗ |
Aug 5, 2026 accepted 4:10 PM ET | 2.02Earnings release7.01Reg FD disclosure | DocumentSEC ↗ |
Jul 29, 2026 accepted 8:15 AM ET | 8-K/A 9.01Exhibits | DocumentSEC ↗ |
Jul 28, 2026 accepted 8:20 AM ET | 1.01Material agreement7.01Reg FD disclosure | DocumentSEC ↗ |
Jul 24, 2026 accepted 4:38 PM ET | 3.01Delisting notice | DocumentSEC ↗ |
Jun 18, 2026 accepted 4:30 PM ET | 5.02Officer / director change5.07Shareholder vote | DocumentSEC ↗ |
Jun 8, 2026 accepted 8:31 AM ET | 1.01Material agreement3.02Unregistered equity sale5.01Change in control5.02Officer / director change7.01Reg FD disclosure | DocumentSEC ↗ |
Jun 5, 2026 accepted 5:01 PM ET | 8.01Other events | DocumentSEC ↗ |